Raymond James Maintains Strong Buy on Biohaven Ltd. (BHVN) March 2026

Raymond James on March 09, 2026 maintained a Strong Buy on Biohaven Ltd. (BHVN), keeping its positive stance on the company’s pipeline and specifically on opakalim. The StreetInsider summary shows no price or price target attached to the note, and Raymond James’ action is recorded as a maintained Strong Buy. This BHVN analyst rating underlines continued institutional confidence while leaving near-term price guidance unspecified.